Abstract
Acne vulgaris is a common dermatologic disease affecting 40 to 50 million individuals in the United States each year. It has a peak incidence in adolescents and young adults; however, for some patients, the disease may persist well into adulthood. These incidence peaks coincide with the age demographic of a large proportion of military service members. Although there are many approaches to treating acne, active-duty service members and military dermatologists must weigh multiple additional challenging factors when selecting a therapy. Untreated acne itself may hinder a military service member's ability to perform, and many of the available therapies also can limit their medical readiness or fitness for full duty. Herein, we review operational restrictions to acne-specific therapeutics and discuss an accelerated course of oral isotretinoin as a safe and effective option for military service members bound by duty restrictions and operational timelines. In addition, we explore the role of teledermatology for the treatment of acne in military service members.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
